Research graph
References from Autoantibody Screening of Siblings in the Teplizumab Era: From a Single Measurement to Treatable Stages of Type 1 Diabetes. Local targets link to admitted publications; unresolved targets remain external evidence.
Long‐Term Follow‐Up Incidence of Type 1 Diabetes and Associated Autoimmune Diseases in First‐Degree Relatives
10.1111/dom.71194 · 2026 · External reference
Staging Presymptomatic Type 1 Diabetes: A Scientific Statement of JDRF, the Endocrine Society, and the American Diabetes Association
10.2337/dc15-1419 · 2015 · External reference
An Anti‐CD3 Antibody, Teplizumab, in Relatives at Risk for Type 1 Diabetes
10.1056/nejmoa1902226 · 2019 · External reference
Teplizumab: A Disease‐Modifying Therapy for Type 1 Diabetes That Preserves β‐Cell Function
10.2337/dc23-0675 · 2023 · External reference
An International Consensus on Screening and Monitoring Early‐Stage Type 1 Diabetes: A Roadmap to European Implementation
10.1111/dom.70569 · 2026 · External reference
From Screening to Delivery of Disease‐Modifying Therapy: Real World Follow‐Up of Children With Early‐Stage Type 1 Diabetes
10.1111/dom.70689 · 2026 · External reference
Seroconversion to Multiple Islet Autoantibodies and Risk of Progression to Diabetes in Children
10.1001/jama.2013.6285 · 2013 · External reference
Impact of Autoimmune Hypothyroidism and Celiac Disease on Progression to Diabetes in Individuals Positive for GAD65 or IA‐2 Autoantibodies
10.1111/dom.71044 · 2026 · External reference
Autoimmune Gastritis in Type 1 Diabetes: A Clinically Oriented Review
10.1210/jc.2007-2134 · 2008 · External reference
Early Clinical Indicators of Addison Disease in Adults With Type 1 Diabetes: A Nationwide, Observational, Cohort Study
10.1210/jc.2018-02064 · 2019 · External reference
Yield of a Public Health Screening of Children for Islet Autoantibodies in Bavaria, Germany
10.1001/jama.2019.21565 · 2020 · External reference
Screening Children for Early‐Stage Type 1 Diabetes
10.1001/jama.2026.6085 · 2026 · External reference
